This association becomes particularly evident when analyzing specific clinical subgroups, N1 + N2 group with lymph node metastasis, M1 group with distant metastasis, and III + IV tumor stage group all exhibited significantly greater levels of PLOD3 expression (Fig. S1D–F). This evidence concerns the gene PLOD3 and neoplasm.